KZA 0.00% 8.0¢ kazia therapeutics limited

San Antonio Breast Cancer Symposium 8 Dec, page-28

  1. 1,080 Posts.
    lightbulb Created with Sketch. 122
    Correction: Kazia is commencing a GBM agile phase TWO trial sometime next year. NOT a phase 3 trial. The sequential phase three trial completion is two to three years away and it will only start if the P2 is successful completed. By that time the better performing competitors drug has a good chance of being up and running. That will be good news for patients
    As always this is my opinion and not advice

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.